ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Diluted EPS

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥12.38T
P/E ratio
26.8x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Dec 31, 2025263.7+12.05%
Dec 31, 2024235.4+18.99%
Dec 31, 2023197.8-13.08%
Dec 31, 2022227.6+23.57%
Dec 31, 2021184.2+41.09%
Dec 31, 2020130.5-54.59%
Dec 31, 2019287.4+82.01%
Dec 31, 2018157.9+23.99%
Dec 31, 2017127.4+36.85%
Dec 31, 201693.1-9.46%
Dec 31, 2015102.8+9.91%
Dec 31, 201493.5+0.73%
Dec 31, 201392.8+4.86%
Dec 31, 201288.5+36.78%
Dec 31, 201164.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat